Lifecore Biomedical is dedicated to the development of technically advanced hyaluronan based products.
Lifecore Biomedical is dedicated to the development of technically advanced hyaluronan based products that offer long-term compatibility with the human body.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 25, 2022 | Post-IPO Equity | $5M | 1 | Wynnefield Capital Advisors | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Wynnefield Capital Advisors | Yes | Post-IPO Equity |